Free Trial

ANGLE (AGL) Competitors

ANGLE logo
GBX 8.40 -0.35 (-4.00%)
As of 12:20 PM Eastern

AGL vs. SSY, FME, BNR, CON, AMED, SHC, TALK, AMS, DXRX, and YGEN

Should you be buying ANGLE stock or one of its competitors? The main competitors of ANGLE include Scisys Group (SSY), Future Metals (FME), Burning Rock Biotech (BNR), Connemara Mining (CON), Amedeo Resources (AMED), Shaftesbury Capital (SHC), TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Diaceutics (DXRX), and Yourgene Health (YGEN).

ANGLE vs.

Scisys Group (LON:SSY) and ANGLE (LON:AGL) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, community ranking, earnings, dividends, analyst recommendations, valuation and media sentiment.

Scisys Group has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Scisys Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scisys Group£59.06M0.00N/A£1.40N/A
ANGLE£2.44M11.08-£21.76M-£6.76-1.24

ANGLE received 78 more outperform votes than Scisys Group when rated by MarketBeat users. Likewise, 62.46% of users gave ANGLE an outperform vote while only 42.34% of users gave Scisys Group an outperform vote.

CompanyUnderperformOutperform
Scisys GroupOutperform Votes
105
42.34%
Underperform Votes
143
57.66%
ANGLEOutperform Votes
183
62.46%
Underperform Votes
110
37.54%

In the previous week, Scisys Group's average media sentiment score of 0.00 equaled ANGLE'saverage media sentiment score.

Company Overall Sentiment
Scisys Group Neutral
ANGLE Neutral

18.8% of ANGLE shares are held by institutional investors. 16.2% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Scisys Group has a net margin of 0.00% compared to ANGLE's net margin of -890.91%. Scisys Group's return on equity of 0.00% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
Scisys GroupN/A N/A N/A
ANGLE -890.91%-76.01%-29.89%

ANGLE has a consensus price target of GBX 40, indicating a potential upside of 376.19%. Given ANGLE's stronger consensus rating and higher possible upside, analysts plainly believe ANGLE is more favorable than Scisys Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scisys Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

ANGLE beats Scisys Group on 7 of the 13 factors compared between the two stocks.

Get ANGLE News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

MetricANGLEDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£27.07M£772.26M£5.55B£2.59B
Dividend Yield1.12%5.44%5.09%4.97%
P/E Ratio-1.241.8922.75133.69
Price / Sales11.08482.17403.97239,757.82
Price / Cash5.8011.4238.1828.12
Price / Book0.922.746.794.55
Net Income-£21.76M£308.37B£3.22B£5.84B
7 Day Performance-8.50%-0.17%2.30%3.43%
1 Month Performance-11.58%3.89%3.64%10.59%
1 Year Performance-38.91%-7.75%16.87%117.06%

ANGLE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
ANGLE
1.642 of 5 stars
GBX 8.40
-4.0%
GBX 40
+376.2%
-38.2%£27.07M£2.44M-1.24650
SSY
Scisys Group
N/AN/AN/AN/A£75.14M£59.06M180.711,376
FME
Future Metals
N/AGBX 0.53
-3.6%
N/A-63.4%£6.06M£155,836.16-1.54123,200Gap Down
BNR
Burning Rock Biotech
N/AN/AN/AN/A£3.77MN/A0.001,390Gap Down
High Trading Volume
CON
Connemara Mining
N/AN/AN/AN/A£1.52MN/A-3.83N/A
AMED
Amedeo Resources
N/AN/AN/AN/A£0.00N/A0.0020,000
SHC
Shaftesbury Capital
1.8515 of 5 stars
GBX 129
-0.2%
GBX 174
+34.9%
+1.1%£2.50B£241.46M62.753,000Analyst Forecast
News Coverage
TALK
TalkTalk Telecom Group
N/AN/AN/AN/A£1.11B£1.52B7.57500High Trading Volume
AMS
Advanced Medical Solutions Group
2.0925 of 5 stars
GBX 182.80
+0.1%
GBX 300
+64.1%
+2.5%£394.72M£132.18M35.4210
DXRX
Diaceutics
2.8826 of 5 stars
GBX 117
-3.3%
GBX 160
+36.8%
+22.3%£98.74M£26.08M-34.70151News Coverage
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253

Related Companies and Tools


This page (LON:AGL) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners